Tuesday, March 9, 2010

MIT is developing inner ear drug delivery device

Harvard Medical School and MIT seem to be developing a inner ear drug delivery device. See link below.

I surmise from the materials that they must have some sort of effective drug up their sleeve already. It is some sort of solid dry drug, that need to be continuously delivered (controlled by a microprocessor) over years into the inner ear to be effective, something to do with the Atoh1 gene which Genvec is partnering Novartis to co-develop with a war chest of over US$200 million.

And it follows from the above (eg that it need to be continuously delivered over years)that it is not only for repairing damaged hair cells in 10-days old patients only (see my other report or 2nd link below) :

http://www.usher-syndrome.org/index.cfm?pk=download&id=10711&pid=10258

http://www.newscientist.com/article/mg20527494.800-ten-days-to-save-hearing-after-deafening-sound.html

No comments: